BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 175322)

  • 1. Hydatidiform mole: a vascular congenital anomaly.
    Reynolds SR
    Obstet Gynecol; 1976 Feb; 47(2):244-50. PubMed ID: 175322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
    Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
    Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of the trans-generational effect in the high incidence of the hydatidiform mole in Africa.
    Coullin P; Diatta AL; Boufettal H; Feingold J; Leguern E; Candelier JJ
    Placenta; 2015 Jan; 36(1):48-51. PubMed ID: 25468544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculogenesis in complete and partial hydatidiform mole pregnancies studied with CD34 immunohistochemistry.
    Lisman BA; Boer K; Bleker OP; van Wely M; Exalto N
    Hum Reprod; 2005 Aug; 20(8):2334-9. PubMed ID: 15878926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the production of chorionic gonadotropin by the cells of trophoblastic tumors (immunohistochemical research)].
    Pozharisskiĭ KM; Zueva EE; Nikitin AIu
    Vopr Onkol; 1988; 34(8):945-51. PubMed ID: 2844022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP
    Pathobiol Annu; 1981; 11():391-411. PubMed ID: 6276846
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in the epidemiology of gestational trophoblastic disease.
    Palmer JR
    J Reprod Med; 1994 Mar; 39(3):155-62. PubMed ID: 8035370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole.
    Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O
    Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic and immunohistochemical evaluation of blood vessels in complete and partial hydatidiform mole.
    Dickson-González SM; García de Barriola V; Barbella-Aponte RA; Figueira L; Cortés-Charry R; Naranjo de Gómez M
    J Reprod Med; 2006 Dec; 51(12):933-7. PubMed ID: 17253040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective placentation and resultant oxidative stress play a role in complete hydatidiform mole.
    Harma M; Harma M; Lash GE; Bulmer JN
    Placenta; 2009 Apr; 30(4):375; author reply 376. PubMed ID: 19246090
    [No Abstract]   [Full Text] [Related]  

  • 14. A case-control study of trophoblastic diseases in the People's Republic of China.
    Wu PC; Brinton LA; Wang W; Sung HC; Ershow AG; Li JY; Blot WJ
    Natl Cancer Inst Monogr; 1985 Dec; 69():15-8. PubMed ID: 3010120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum protein distribution in hydatidiform mole. An immunohistochemical study.
    Massi G; Coli A; De Carolis S
    Arch Pathol Lab Med; 1987 Aug; 111(8):723-5. PubMed ID: 3307688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk factors in the development of persistent trophoblastic disease following hydatidiform mole.
    Tangtrakul S; Srisupundit S; Linasmita V; Bullangpoti S; Bhamarapravati Y
    J Med Assoc Thai; 1990 Feb; 73 Suppl 1():33-6. PubMed ID: 2161897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods.
    Kim MJ; Kim KR; Ro JY; Lage JM; Lee HI
    Am J Surg Pathol; 2006 Mar; 30(3):362-9. PubMed ID: 16538057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trophoblastic tumor at the site of the placenta].
    Białas B
    Patol Pol; 1989; 40(2):239-41. PubMed ID: 2561608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydatidiform mole with a surviving coexistent fetus following in-vitro fertilization.
    Jinno M; Ubukata Y; Hanyu I; Satou M; Yoshimura Y; Nakamura Y
    Hum Reprod; 1994 Sep; 9(9):1770-2. PubMed ID: 7836536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.